Skip to main content
Erschienen in: Endocrine Pathology 3/2008

01.09.2008

Metastatic Small Cell Carcinoma to the Thyroid Gland: a Pathologic and Molecular Study Demonstrating the Origin in the Urinary Bladder

verfasst von: Soraya Puente, Ana Velasco, Pilar Gallel, Judit Pallares, Luis Perez-Ruiz, Susana Ros, Javier Maravall, Xavier Matias-Guiu

Erschienen in: Endocrine Pathology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Small cell carcinomas may occur in the thyroid gland. Infrequently, they are primary tumors, and have been interpreted as variants of medullary thyroid carcinoma. However, the vast majority of small cell carcinomas involving the thyroid gland are metastatic tumors. In some cases, demonstration of the primary tumor is not easy. An example of a small cell carcinoma metastatic to the thyroid is presented in this report. The primary tumor was a small cell carcinoma that occurred as a minor component in a transitional carcinoma of the urinary bladder. The microscopical and immunohistochemical features of both tumors, in the thyroid and the bladder, were identical. Moreover, both tumors exhibited an identical mutation in p53, as well as similar loss of heterozygosity at 10q23 and RASSF1A promoter hypermethylation, clearly indicating that the bladder tumor was the site for the primary tumor of the patient.
Literatur
1.
Zurück zum Zitat Eusebi V, Damiani S, Riva C, Lloyd RV, Capella C. Calcitonin free oat-cell carcinoma of the thyroid gland. Virchows Arch A Pathol Anat Histopathol 417:267–71, 1990.PubMedCrossRef Eusebi V, Damiani S, Riva C, Lloyd RV, Capella C. Calcitonin free oat-cell carcinoma of the thyroid gland. Virchows Arch A Pathol Anat Histopathol 417:267–71, 1990.PubMedCrossRef
2.
Zurück zum Zitat Matias-Guiu X, DeLellis RA, Moley JF. Medullary thyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, et al., editors. Pathology and genetics of tumors of endocrine organs: WHO classification of tumors. Lyon: IARC; pp. 86–91, 2004. Matias-Guiu X, DeLellis RA, Moley JF. Medullary thyroid carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, et al., editors. Pathology and genetics of tumors of endocrine organs: WHO classification of tumors. Lyon: IARC; pp. 86–91, 2004.
3.
Zurück zum Zitat Matias-Guiu X, LaGuette J, Puras-Gil AM, Rosai J. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases. Am J Surg Pathol 21:754–62, 1997.PubMedCrossRef Matias-Guiu X, LaGuette J, Puras-Gil AM, Rosai J. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases. Am J Surg Pathol 21:754–62, 1997.PubMedCrossRef
4.
Zurück zum Zitat Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, et al. Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR. J Endocrinol Invest 28:371–8, 2005.PubMed Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P, Del Vecchio S, et al. Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR. J Endocrinol Invest 28:371–8, 2005.PubMed
5.
Zurück zum Zitat Mendelsohn G, Baylin SB, Bigner SH, Wells SA Jr, Eggleston JC. Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol 4:333–41, 1980.PubMedCrossRef Mendelsohn G, Baylin SB, Bigner SH, Wells SA Jr, Eggleston JC. Anaplastic variants of medullary thyroid carcinoma: a light-microscopic and immunohistochemical study. Am J Surg Pathol 4:333–41, 1980.PubMedCrossRef
6.
Zurück zum Zitat Tsutsumi Y. Immunohistochemical analysis of calcitonin and calcitonin gene-related peptide in human lung. Hum Pathol 20:896–902, 1989.PubMedCrossRef Tsutsumi Y. Immunohistochemical analysis of calcitonin and calcitonin gene-related peptide in human lung. Hum Pathol 20:896–902, 1989.PubMedCrossRef
7.
Zurück zum Zitat Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 109:364–71, 1988.PubMed Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 109:364–71, 1988.PubMed
8.
Zurück zum Zitat Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 103:1172–8, 2005.PubMedCrossRef Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 103:1172–8, 2005.PubMedCrossRef
9.
Zurück zum Zitat Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101:957–62, 2004.PubMedCrossRef Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101:957–62, 2004.PubMedCrossRef
10.
Zurück zum Zitat Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 36:718–23, 2005.PubMedCrossRef Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 36:718–23, 2005.PubMedCrossRef
11.
Zurück zum Zitat Fujita T, Kiyama M, Tomizawa Y, Kohno T, Yokota J. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int J Oncol 15:927–34, 1999.PubMed Fujita T, Kiyama M, Tomizawa Y, Kohno T, Yokota J. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int J Oncol 15:927–34, 1999.PubMed
12.
Zurück zum Zitat Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, et al. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 25:2001–4, 2005.PubMed Wang X, Jones TD, Maclennan GT, Yang XJ, Lopez-Beltran A, Eble JN, et al. P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 25:2001–4, 2005.PubMed
13.
Zurück zum Zitat Han B, Mori I, Wang X, Nakamura M, Nakamura Y, Kakudo K. Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components. Int J Exp Pathol 86:213–8, 2005.PubMedCrossRef Han B, Mori I, Wang X, Nakamura M, Nakamura Y, Kakudo K. Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components. Int J Exp Pathol 86:213–8, 2005.PubMedCrossRef
14.
Zurück zum Zitat Gallardo A, Matias-Guiu X, Lagarda H, Catasus L, Bussaglia E, Gras E, et al. Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases. Int J Gynecol Pathol 21:268–72, 2002.PubMedCrossRef Gallardo A, Matias-Guiu X, Lagarda H, Catasus L, Bussaglia E, Gras E, et al. Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases. Int J Gynecol Pathol 21:268–72, 2002.PubMedCrossRef
Metadaten
Titel
Metastatic Small Cell Carcinoma to the Thyroid Gland: a Pathologic and Molecular Study Demonstrating the Origin in the Urinary Bladder
verfasst von
Soraya Puente
Ana Velasco
Pilar Gallel
Judit Pallares
Luis Perez-Ruiz
Susana Ros
Javier Maravall
Xavier Matias-Guiu
Publikationsdatum
01.09.2008
Verlag
Humana Press Inc
Erschienen in
Endocrine Pathology / Ausgabe 3/2008
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-008-9024-4

Weitere Artikel der Ausgabe 3/2008

Endocrine Pathology 3/2008 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …